EANS-News: Symrise AG´s annual general meeting elects two new supervisory board members

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Annual & Special Corporate Meetings

Holzminden (euro adhoc) - • Prof. Dr. Andrea Pfeifer and Dr. Michael
Becker newly elected to supervisory board • Dr. Thomas Rabe is new
chairman of the supervisory board • Higher dividend of EUR 0.60 (+
20%) approved

At the 2011 annual general meeting of Symrise AG, which was held in
Hannover today, all proposals were approved by a large majority of
the shareholders in attendance. The agenda included a vote on
increasing the dividend by 20 % over the previous year to EUR 0.60
per share and the election of two new shareholder representatives to
the supervisory board. The shareholders in attendance represented 72%
of the equity.

In his speech to the approximate 300 shareholders, Chief Executive
Officer Dr. Heinz-Jürgen Bertram looked back at the extraordinarily
successful fiscal year 2010. Symrise benefited from the global
economic recovery and a strong boost in demand, as well as the
excellent positioning in emerging markets and the business with large
customers. The Group has had a good start in the current financial
year. The results for the first quarter confirm that the Group is
well positioned to achieving its objectives for 2011.

An important item on the agenda was the election of the shareholder
representatives to the supervisory board, as the term of all members
expired at this year´s general meeting. Andreas Schmid, supervisory
board chairman to date, as well as shareholder representative Sanna
Suvanto-Harsaae had indicated prior to the meeting that they would
not stand for reelection due to personal or professional reasons. The
management and supervisory board thanked Mr. Schmid and Mrs.
Suvanto-Harsaae for their dedicated work in past years.

Dr. Michael Becker, a personally liable partner and member of the
management board of Merck KGaA, Darmstadt, and Prof. Dr. Andrea
Pfeifer, chief executive officer of AC Immune S.A., Légier,
Switzerland, were newly elected to the supervisory board. The
previous shareholder representatives Horst-Otto Gerberding, Dr. Peter
Grafoner, Dr. Hans-Heinrich Gürtler and Dr. Thomas Rabe were
reconfirmed to their posts on the supervisory board. Dr. Rabe was
elected supervisory board chairman at a constituent session of the
supervisory board following the annual general meeting.

In selecting the new shareholder representatives the nomination
committee placed special emphasis on comprehensive expertise in
fields relevant to the company, a strong scientific background and
extensive management experience.

Dr. Heinz-Jürgen Bertram said: "We are very glad to be able to
welcome to our supervisory board two top-class and experienced
managers, namely Professor Pfeifer and Dr. Becker. Both bring with
them extensive sector expertise and management experience that will
be very valuable to Symrise."

Dr. Michael Becker has been a member of the management board of Merck
KGaA for over ten years. Among other things he heads the departments
of accounting, controlling, finance, mergers & acquisitions, investor
relations and purchasing.

Prof. Dr. Andrea Pfeifer is the founder and chief executive officer
of AC Immune SA in Switzerland, a professor at the University of
Lausanne, administrative board president of BioMedinvestor AG, Basel,
Switzerland, and has extensive experience in the field of molecular
and cell research. As a member of the supervisory board Prof. Dr.
Pfeifer will, among other things, support Symrise in increasing its
strategic focus on the field of consumer health.

About Symrise

Symrise is a global supplier of fragrances, flavorings and raw
materials as well as active ingredients for the perfume, cosmetics
and food industry.

Its sales of EUR 1.572 billion in 2010 place the Company among the
top four in the international flavor and fragrance market.
Headquartered in Holzminden, Germany, Symrise is represented in more
than 35 countries in Europe, Asia, the United States and South
America.

Used by manufacturers of perfumes, cosmetics and foods, our
innovative products are an inseparable part of daily life. At Symrise
we combine an awareness of consumer trends with cutting-edge
technologies, focusing on developing innovative fashion and lifestyle
products that have additional practical value for the consumer.
Symrise - always inspiring more…

www.symrise.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Symrise AG
Mühlenfeldstraße 1
D-37603 Holzminden
phone: +49 (0) 5531/90-0
FAX: +49 (0) 5531/90-1649
mail: ir@symrise.com
WWW: http://www.symrise.com
sector: Chemicals
ISIN: DE000SYM9999
indexes: MDAX
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Hamburg, Stuttgart, Düsseldorf, Hannover, München
language: English

ots Originaltext: Symrise AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Symrise AG
Bernhard Kott
Phone +49 (0)5531 90-1721
Email: bernhard.kott@symrise.com

Branche: Chemicals
ISIN: DE000SYM9999
WKN: SYM999
Index: MDAX
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade